Morepen Laboratories Limited (NSE:MOREPENLAB)
India · Delayed Price · Currency is INR 35.35
-1.85 (-4.97%)
Apr 2, 2026, 10:30 AM IST
Morepen Laboratories Market Cap
Morepen Laboratories has a market cap or net worth of 20.39 billion as of April 1, 2026. Its market cap has decreased by -25.06% in one year.
Market Cap
20.39B
Enterprise Value
21.17B
Revenue
17.87B
Ranking
n/a
PE Ratio
20.50
Stock Price
35.35
Market Cap Chart
Since October 8, 1999, Morepen Laboratories's market cap has increased from 8.66B to 20.39B, an increase of 135.50%. That is a compound annual growth rate of 3.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 18.52B | -17.70% |
| Dec 31, 2025 | 22.50B | -47.55% |
| Dec 31, 2024 | 42.90B | 72.95% |
| Dec 29, 2023 | 24.81B | 28.39% |
| Dec 30, 2022 | 19.32B | -23.70% |
| Dec 31, 2021 | 25.33B | 83.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innova Captab | 39.48B |
| Sun Pharma Advanced Research Company | 37.28B |
| RPG Life Sciences | 30.72B |
| Orchid Pharma | 24.47B |
| Solara Active Pharma Sciences | 20.50B |
| Windlas Biotech | 15.53B |
| Indoco Remedies | 15.14B |
| Jagsonpal Pharmaceuticals | 12.32B |